# Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity

> **NCT04044872** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 3 (actual)

## Conditions studied

- Thoracic Cancer
- Left Sided Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** [1-13C]pyruvate along with MRI imaging

## Key facts

- **NCT ID:** NCT04044872
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-17
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** It has been terminated due to investigator decision to no longer pursue grant funding to support the study.
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04044872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04044872, "Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04044872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*